Needham Maintains Buy on OrthoPediatrics, Lowers Price Target to $37

Benzinga · 11/07/2023 18:30
Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and lowers the price target from $55 to $37.